Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer
Clinical trial NCT00171808 · COMPLETED
Trial details
- NCT number
- NCT00171808
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2010-05-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.